Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Spiera

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Arthritis and Rheumatism|April 13, 2011
Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohortFrancisco Silva, Philip Seo, Darrell R Schroeder, et al.
The Journal of Rheumatology|October 9, 2007
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic eventJodi K Sebastian, Barbara Voetsch, John H Stone, et al.
Arthritis and Rheumatism|June 30, 2005
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Philip Seo, Yuan-I Min, Janet T Holbrook, et al.
The American Journal of Medicine|December 28, 2005
Herpes zoster in immunocompromised patients: incidence, timing, and risk factorsPeter K Wung, Janet T Holbrook, Gary S Hoffman, et al.
ACR Open Rheumatology|November 18, 2021
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated VasculitisPaul A Monach, Roscoe L Warner, Robert Lew, et al.
JCI Insight|December 27, 2016
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severityShane Lofgren, Monique Hinchcliff, Mary Carns, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 27, 2018
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated VasculitisRennie L Rhee, John C Davis, Linna Ding, et al.
JCI Insight|August 26, 2020
Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitisKasia Owczarczyk, Matthew D Cascino, Cecile Holweg, et al.
Annals of Internal Medicine|November 3, 2007
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosisJavier D Finkielman, Peter A Merkel, Darrell Schroeder, et al.
Arthritis and Rheumatism|April 29, 2006
Solid malignancies among patients in the Wegener's Granulomatosis Etanercept TrialJohn H Stone, Janet T Holbrook, Matthew A Marriott, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Arthritis and Rheumatism|April 13, 2011
Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohortFrancisco Silva, Philip Seo, Darrell R Schroeder, et al.
The Journal of Rheumatology|October 9, 2007
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic eventJodi K Sebastian, Barbara Voetsch, John H Stone, et al.
Arthritis and Rheumatism|June 30, 2005
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Philip Seo, Yuan-I Min, Janet T Holbrook, et al.
The American Journal of Medicine|December 28, 2005
Herpes zoster in immunocompromised patients: incidence, timing, and risk factorsPeter K Wung, Janet T Holbrook, Gary S Hoffman, et al.
ACR Open Rheumatology|November 18, 2021
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated VasculitisPaul A Monach, Roscoe L Warner, Robert Lew, et al.
JCI Insight|December 27, 2016
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severityShane Lofgren, Monique Hinchcliff, Mary Carns, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 27, 2018
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated VasculitisRennie L Rhee, John C Davis, Linna Ding, et al.
JCI Insight|August 26, 2020
Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitisKasia Owczarczyk, Matthew D Cascino, Cecile Holweg, et al.
Annals of Internal Medicine|November 3, 2007
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosisJavier D Finkielman, Peter A Merkel, Darrell Schroeder, et al.
Arthritis and Rheumatism|April 29, 2006
Solid malignancies among patients in the Wegener's Granulomatosis Etanercept TrialJohn H Stone, Janet T Holbrook, Matthew A Marriott, et al.
Pageof 10